Sotabase

Career

· Doctor of Philosophy - PhD, Computer Software Engineering, Monash University2022–2025
· Financial Analyst, AI Australia2020–2021
· Master's degree, Information of Technology, WAM82, Monash University2020–2021
· Co-Founder, MGT2017–2018
· Bachelor's degree, EDUCATION, GPA 3.6, National Taiwan Normal University2016–2019
· Lecturer At, University of Melbourne

Publications (175)

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
European Heart Journal · 2013
2,975
cited
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
European Heart Journal · 2019
1,332
cited
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Nature Medicine · 2022
646
cited
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
Circulation · 2015
591
cited
Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
JACC. Heart failure · 2017
334
cited
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
European Journal of Heart Failure · 2020
242
cited
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
European Heart Journal · 2015
207
cited
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.
European Heart Journal · 2020
169
cited
Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction.
Clinical Chemistry · 2012
157
cited
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Nature Medicine · 2023
136
cited
Prognostic Significance of Resting Heart Rate and Use of &bgr;-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry
Circulation: Heart Failure · 2015
119
cited
Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways.
American Journal of Physiology. Heart and Circulatory Physiology · 2006
115
cited
Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy.
Journal of Autoimmunity · 2003
107
cited
Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality.
Journal of the American College of Cardiology · 2013
107
cited
Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy.
European Heart Journal · 2004
106
cited
Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio
Clinical Research in Cardiology · 2010
101
cited
Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management
Heart Failure Reviews · 2013
100
cited
Stromal Vascular Fraction Transplantation as an Alternative Therapy for Ischemic Heart Failure: Anti-inflammatory Role
Journal of Cardiothoracic Surgery · 2011
94
cited
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure
European Heart Journal · 2014
93
cited
Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes.
European Journal of Pharmacology · 2003
85
cited
Sotabase
Michael Fu | Researcher Profile | Sotabase | Sotabase